Our findings combined with dysregulation in a genetic modified ovarian cancer cell line model rendered non-tumourigenic which resulted in the up-regulation of IGFBP7, supports a role in tumour suppressor pathways. The gene discussed is IGFBP7; the disease is ovarian carcinoma.